1Muller RH, Mehnert W, Lucks JS, et al. Solid lipid nanoparticles(SLN) - an alternative colloidal carrier system for controlled drug delivery[J]. Eur J Pharm Biopharm,1995, 41(1):62-69.
2Mehnert W, Mader K. Solid lipid nanoparticles: production, characterization and applications[J]. Adv Drug Deliv Rev, 2001, 47(2/3): 165 - 196.
3Siekmann B, Westesen K. Investigations on solid lipid nanoparticles prepared by precipitation in o/w emulsions [J]. Eur J Pharm Biopharm, 1996,43(2): 104 - 109.
4Ahlin P, Kristl J, Sentjurc M, et al. Influence of spin probe structure on its distribution in SLN dispersions[J].Int J Pharm, 2000, 196(2) :241 - 244.
5Jenning V, Gohla SH. Encapsulation of retinoids in solid lipid nanoparticles(SLN)[J]. J Microencapsul, 2001, 18(2): 149 - 158.
6Muller RH, Mader K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art[J]. Eur J Pharm Biopharm, 2000, 50( 1 ): 161 -177.
7zur-Muhlen A, Schwarz C, Mehnert W. Solid lipid nanoparticles(SLN) for controlled drug delivery- drug release and release mechanism[J]. Eur J Pharm Biopharm, 1998,45(2): 149 - 155.
8Olbrich C, Muller RH. Enzymatic degradation of SLN-effect of surfactant and surfactant mixtures [J]. Int J Pharm,1999, 180(1) :31 - 39.
9Yang SC, Lu LF, Cai Y, et al. Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain [J]. J Control Release,1999, 59(3) :299 - 307.
10Hodoshima N, Udagawa C, Audo T, et al. Lipid nanoparticles for delivering antitumor drugs [J]. Int J Pharm,1997, 146(1):81-92.
